Coronary balloon angioplasty, stents, and scaffolds
Since the first coronary angioplasty on Sept 16, 1977, the field of percutaneous coronary
intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary …
intervention has evolved rapidly. Now marking its 40th anniversary, percutaneous coronary …
IVUS-guided versus OCT-guided coronary stent implantation: a critical appraisal
Procedural guidance with intravascular ultrasound (IVUS) imaging improves the clinical
outcomes of patients undergoing percutaneous coronary intervention (PCI) by: 1) informing …
outcomes of patients undergoing percutaneous coronary intervention (PCI) by: 1) informing …
Comparison of an everolimus-eluting bioresorbable scaffold with an everolimus-eluting metallic stent for the treatment of coronary artery stenosis (ABSORB II): a 3 …
PW Serruys, B Chevalier, Y Sotomi, A Cequier… - The Lancet, 2016 - thelancet.com
Background No medium-term data are available on the random comparison between
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …
everolimus-eluting bioresorbable vascular scaffolds and everolimus-eluting metallic stents …
Bioresorbable scaffolds versus metallic stents in routine PCI
JJ Wykrzykowska, RP Kraak, SH Hofma… - … England Journal of …, 2017 - Mass Medical Soc
Background Bioresorbable vascular scaffolds were developed to overcome the
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …
shortcomings of drug-eluting stents in percutaneous coronary intervention (PCI). We …
3-year clinical outcomes with everolimus-eluting bioresorbable coronary scaffolds: the ABSORB III trial
DJ Kereiakes, SG Ellis, C Metzger, RP Caputo… - Journal of the American …, 2017 - jacc.org
Abstract Background: The Absorb everolimus-eluting poly-L-lactic acid–based
bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support …
bioresorbable vascular scaffold (BVS) provides early drug delivery and mechanical support …
Predictors of stent thrombosis and their implications for clinical practice
Stent thrombosis (ST) is a rare but severe complication of coronary procedures with high
mortality, high relapse rate and a very complex pathophysiology. An individual's …
mortality, high relapse rate and a very complex pathophysiology. An individual's …
Restenosis, stent thrombosis, and bleeding complications: navigating between Scylla and Charybdis
The field of interventional cardiology has significantly evolved over 40 years by overcoming
several challenges. The introduction of first-generation drug-eluting stents significantly …
several challenges. The introduction of first-generation drug-eluting stents significantly …
2-year outcomes with the Absorb bioresorbable scaffold for treatment of coronary artery disease: a systematic review and meta-analysis of seven randomised trials …
Background Bioresorbable vascular scaffolds (BVS) offer the potential to improve long-term
outcomes of percutaneous coronary intervention after their complete bioresorption …
outcomes of percutaneous coronary intervention after their complete bioresorption …
Three-year outcomes with the absorb bioresorbable scaffold: individual-patient-data meta-analysis from the ABSORB randomized trials
Background: The Absorb bioresorbable vascular scaffold (BVS) completely resorbs within 3
years after coronary artery implantation. The safety and effectiveness of BVS through this …
years after coronary artery implantation. The safety and effectiveness of BVS through this …
JCS/JSCVS 2018 guideline on revascularization of stable coronary artery disease
M Nakamura, H Yaku, J Ako, H Arai, T Asai… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for elective percutaneous
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …
coronary intervention [PCI] in patients with stable coronary disease” in 2000. In 2006 …